Clinical Trial Update: An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders

View source ↗

Summary

An extension study to evaluate the safety and efficacy of an anti-CD19 CAR-T product in patients with B-cell lymphoproliferative disorders, currently not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• Anti-CD19 CAR-T product

Snippet

Sponsor: National Research Center for Hematology, Russia | Conditions: Non-Hodgkin Lymphoma, B-cell, Acute Lymphoblastic Leukemia ALL | Status: NOT_YET_RECRUITING